| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thrombosis |
From the National Heart, Lung, and Blood Institute Framingham Heart Study (S.K., Q.Y., M.G.L., C.J.O.), Framingham, Mass; Broad Institute of Harvard University and Massachusetts Institute of Technology (S.K., S.B.G., A.L.C., J.N.H., C.J.O.), Cambridge; Department of Biostatistics (Q.Y.), Boston University School of Public Health, Department of Neurology (Q.Y.), Boston University School of Medicine, Department of Mathematics and Statistics (M.G.L.), Boston University, Massachusetts; Royal North Shore Hospital (G.H.T.), Sydney, Australia; Divisions of Genetics and Endocrinology (J.N.H.), Childrens Hospital and Department of Genetics, Harvard Medical School, Boston, Mass; and Cardiology Division (S.K., C.J.O.), Massachusetts General Hospital, Harvard Medical School, Boston.
Correspondence to Christopher J. ODonnell, MD, MPH, Framingham Heart Study, 73 Mt Wayte Ave, Suite 2, Framingham, MA 01702-5827. E-mail odonnellc{at}nhlbi.nih.gov
Objective We undertook a linkage disequilibrium (LD)based genetic approach to investigate the hypothesis that common sequence variants in 5 thrombosis genes influence plasma hemostatic protein levels or risk of cardiovascular disease (CVD).
Methods and Results In a reference panel, we characterized LD structure at the fibrinogen gene cluster (fibrinogen-ß[FGB], FGA, and FGG), factor VII (F7), and tissue plasminogen activator (PLAT) loci. Forty-one tag single nucleotide polymorphisms (SNPs) were genotyped in 1811 unrelated Framingham Heart Study participants. There were significant associations of 9 FGB SNPs with fibrinogen level (minimum P=0.002) and of 7 F7 SNPs and factor VII level (minimum P<0.0001). SNPs at the PLAT locus were not associated with PLAT level. In stepwise analysis, a single FGB variant explained 1% of the residual variance in fibrinogen level, and 2 F7 SNPs together explained 10% of the residual variance in factor VII level. Two PLAT haplotypes were associated with CVD (multivariable-adjusted global P=0.0004).
Conclusions A comprehensive survey of common sequence variation demonstrates that cis-regulatory SNPs explain a modest proportion of the residual variance in circulating fibrinogen and factor VII level and PLAT haplotypes increase the risk of CVD. Additional studies are warranted to confirm the association of PLAT sequence variation and risk of CVD.
We hypothesized that cis-acting SNPs influence hemostatic protein levels or CVD risk. In Framingham Heart Study participants, a single FGB SNP explained 1% of fibrinogen level variance, and 2 F7 SNPs together explained 10% of F7 level variance. PLAT gene haplotypes were associated with CVD.
Key Words: coagulation fibrinogen genetics myocardial infarction plasminogen activators thrombosis polymorphism
This article has been cited by other articles:
![]() |
V. J. Christiansen, K. W. Jackson, K. N. Lee, and P. A. McKee The effect of a single nucleotide polymorphism on human {alpha}2-antiplasmin activity Blood, June 15, 2007; 109(12): 5286 - 5292. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |